References
- Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631–71.
- Day SC, Cook EF, Funkenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15–23.
- Lagi A, Francini C, Cuomo A. B-type natriuretic peptide (BNP) for diagnosis of cardiac syncope: diagnostic work-up into the emergency department. J Emerg Disast Med 2012;5:1–6.
- Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D. Incidence and prognosis of syncope. N Engl J Med 2002;347:878–85.
- Das BB, Solinger R. Role of natriuretic peptide family in cardiovascular medicine. Cardiovasc Hematol Agents Med Chem 2009;7:29–42.
- Vanderheyden M, Goethals M, Nellens P, Andries E, Brugada P. Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope. Am Heart J 1998;135:67–73.
- Tanimoto K, Yukiiri K, Mizushige K, Takagi Y, Masugata H, Shinomiya K, Hosomi N, Takahashi T, Ohmori K, Kohno M. Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. Am J Cardiol 2004;93:228–30.
- Zhang Q, Jin H, Qi J, Yan H, Du J. Diagnostic value of serum brain natriuretic peptide in syncope in children and adolescents. Acta Paediatr 2013;102:e210–4.
- Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003;45:249–54.
- Nagaya N, Nishikimi T, Uematsu M, Kyotani S, Satoh T, Nakanishi N, Matsuo H, Kangawa K. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. Am Heart J 1998;136:297–301.
- Smith J, Goetze JP, Andersen CB, Vejlstrup N. Practical application of natriuretic peptides in paediatric cardiology, Cardiol Young 2010;20:353–63.
- Rauchenzauner M, Haberlandt E, Foerster S, Ulmer H, Laimer M, Ebenbichler CF, Joannidis M, Zimmerhackl LB, Stein J, Luef G. Brain-type natriuretic peptide secretion following febrile and afebrile seizures – a new marker in childhood epilepsy?Epilepsia 2007;48:101–6.
- Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125–30.
- Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, Coleridge JC. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol 1988;25:R6–13.
- Holmegard HN, Benn M, Kaijer M, Haunsø S, Mehlsen J. Differences in autonomic balance in patients with cardioinhibitory and vasodepressor type of reflex syncope during head-up tilt test and active standing. Scand J Clin Lab Invest 2012;72:265–73.
- Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM. Role of endogenous opioids and catecholamines in vasovagal syncope Eur Heart J 1996;17: 1729–36.
- Jardine DL, Melton IC, Crozier IG, Bennett SI, Donald RA, Ikram H. Neurohormonal response to head-up tilt and its role in vasovagal syncope. Am J Cardiol 1997;79:1302–6.
- Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol 2010; 55:713–21.
- Reed MJ, Newby DE, Coull AJ, Jacques KG, Prescott RJ, Gray AJ. Role of brain natriuretic peptide (BNP) in risk stratification of adult syncope. Emerg Med J 2007;24: 769–73.
- Pfister R, Diedrichs H, Larbig R, Erdmann E, Schneider CA. NT-proBNP for differential diagnosis in patients with syncope. Int J Cardiol 2009;133:51–4.
- Pfister R, Hagemeister J, Esser S, Hellmich M, Erdmann E, Schneider CA. NT-proBNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. Int J Cardiol 2012;155:268–72.